Latest Headlines

  1. MVZ HPH Brings ctDNA Blood Test For Cancer Monitoring To Europe, Based On Haystack MRD® Technology From Quest Diagnostics® 10/17/2025

    MVZ HPH Institute for Pathology and Hematopathology GmbH, today announced the availability of HPH MRD, a new tumor-informed circulating-tumor DNA (ctDNA) blood test for detecting minimal residual disease (MRD) in patients diagnosed with solid tumor cancers.

  2. Broad Clinical Labs Sets New Guinness World Records Title For Fastest DNA Sequencing Technique 10/15/2025

    Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, today announced official recognition by Guinness World Records for achieving the fastest DNA sequencing technique to date.

  3. Augurex Announces Expansion Of Availability Of The JOINTstat Diagnostic Test For Rheumatoid Arthritis With MitogenDx 10/15/2025

    Augurex Life Sciences Corp., a leader in autoimmune-based diagnostics, today announced an agreement with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology diagnostic testing.

  4. Monod Bio Receives Award To Develop A New Diagnostic Test For Preeclampsia Using AI-Designed Proteins 10/15/2025

    Monod Bio, a biotechnology company utilizing AI-powered de novo protein design for diagnostic and research applications, announced today that it has received a $750,000 grant from Grand Challenges, an initiative of the Gates Foundation, to leverage its AI-based protein design technology to develop a next-generation diagnostic test for preeclampsia.

  5. EpiSign Inc. Launches METRIC -- A Cloud-Based Software Platform Transforming Global Access To Epigenomic Diagnostics 10/15/2025

    EpiSign Inc. today announced the launch of METRIC, a next-generation software platform that converts complex epigenomic data into actionable clinical insights.

  6. SPT Labtech And 10x Genomics Partner To Automate Single Cell Workflows 10/14/2025

    SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and 10x Genomics, Inc., a leader in single cell and spatial biology, today announced a strategic partnership to provide automated workflows for single cell research.

  7. 10x Faster Virus Neutralization Testing With Launch Of Integral Molecular's Ready Reporter Virus™ Kit 10/14/2025

    Integral Molecular, a leader in developing innovative tools for antiviral research, announces the launch of its Ready Reporter Virus™ (RRV) neutralization assay kit.

  8. Waters Launches Charge Detection Mass Spectrometry Technology To Accelerate The Development Of Next-Generation Biotherapeutics 10/13/2025

    Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterization for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.

  9. Roche's Elecsys® pTau181 Becomes The Only FDA-Cleared Blood Test For Use In Primary Care To Rule Out Alzheimer's-Related Amyloid Pathology 10/13/2025

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 test, the only blood-based biomarker (BBM) test indicated as an aid in the initial assessment for Alzheimer's disease and other causes of cognitive decline in the primary-care setting.

  10. Breakthrough In Blood Test For Alzheimer's By University Of York Researchers 10/9/2025

    Researchers have made a significant breakthrough in the development of a blood test for Alzheimer’s, creating a new sensor design that is ultra-sensitive, outperforms competing technologies and can be built into a handheld device.